
Flexion Therapeutics, Inc. FLXN
Flexion Therapeutics, Inc. DSO 2011-2026 | FLXN
DSO Jährlich Flexion Therapeutics, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 129 | 187 | 224 | 1.43 K | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.43 K | 129 | 492 |
DSO anderer Aktien in der Pharmaeinzelhändler
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
20.6 | $ 0.88 | -1.69 % | $ 6.47 M | ||
|
Aquestive Therapeutics
AQST
|
103 | $ 4.1 | 1.23 % | $ 438 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
37.5 | $ 22.45 | 1.13 % | $ 3.72 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
Berkeley Lights
BLI
|
103 | - | -7.31 % | $ 87 M | ||
|
Calithera Biosciences
CALA
|
28.8 | - | -10.95 % | $ 876 K | ||
|
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | ||
|
CymaBay Therapeutics
CBAY
|
182 | - | - | $ 3.45 B | ||
|
ChemoCentryx
CCXI
|
3.1 | - | - | $ 3.74 B | ||
|
Cerus Corporation
CERS
|
47 | $ 2.03 | 5.73 % | $ 387 M | ||
|
Caladrius Biosciences
CLBS
|
164 | - | -16.75 % | $ 25.8 M | ||
|
Kazia Therapeutics Limited
KZIA
|
28.7 | $ 13.64 | 9.82 % | $ 1.81 B | ||
|
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.114 | - | - | $ 26.5 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
60.8 | - | - | $ 2.18 B | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Dynavax Technologies Corporation
DVAX
|
56.5 | - | - | $ 2.02 B | ||
|
Editas Medicine
EDIT
|
142 | $ 3.0 | 6.38 % | $ 266 M | ||
|
Edesa Biotech
EDSA
|
97.1 | $ 18.27 | 14.94 % | $ 58.4 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
28.1 | $ 3.19 | 6.69 % | $ 5.25 M | ||
|
Eiger BioPharmaceuticals
EIGR
|
39.7 | - | -9.21 % | $ 2.55 M | ||
|
Eloxx Pharmaceuticals
ELOX
|
157 | - | -5.68 % | $ 8.28 M | ||
|
CureVac N.V.
CVAC
|
13.6 | - | - | $ 867 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
16.8 | - | -13.39 % | $ 1.45 M |